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ABSTRACT
The relationship between coffee drinking and the risk of digestive tract
neoplasms was analyzed in a case-control study of 50 cases of cancer of
the mouth or pharynx, 209 of the esophagus, 397 of the stomach, 455 of
the colon, 295 of the rectum, 151 of the liver, 214 of the pancreas, and
1944 control subjects admitted for acute, non-digestive tract disorders.
There was no significant or consistent association between coffee and
cancers of the mouth or pharynx, esophagus, stomach, liver, or pancreas.
In particular, for pancreatic cancer, the multivariate relative risks for the
intermediate and upper fertiles were 1.05 and 1.01, respectively. There
were significant inverse trends in risk with measures of coffee consump
tion for colon and rectal cancers, the multivariate relative risks according
to fertiles of coffee consumption being 0.86 and 0.64 for colon and 0.97
and 0.66 for rectum. This apparent protection is in agreement with some
(but not all) previous epidemiolÃ³gica! evidence and finds a possible
biological interpretation in terms of interference on bile secretion, causing
reduced bile acid and neutral stero! concentrations in the bowel. In
conclusion, the results of this study, the major interest of which lies in
the opportunity of drawing up an overall pattern of risk for various
digestive neoplasms, offer further reassurance as regards the effects of
coffee on digestive tract carcinogenesis.
INTRODUCTION
Coffee is widely drunk and induces a series of metabolic and
pharmacological effects, including, specifically on the digestive
tract, increased gastric acid, reduced bile acid, and neutral stero!
secretions (1, 2). Further, coffee may contain mutagens, such
as chlorogenic acid and naphthylglyoxal, and at high doses
caffeine impedes DNA repair (3-5). It is thus possible that
coffee interferes with the risk of cancers of the digestive tract.
Since direct epidemiological evidence on this issue is largely
inconsistent, we investigated the relation between coffee con
sumption and the risk of various digestive tract neoplasms on
the basis of a network of case-control studies conducted in
Northern Italy. The large data set and the possibility of simul
taneous comparison of the patterns of risk for various sites give
particular interest to this analysis.
SUBJECTS AND METHODS
The present data were derived from an ongoing case-control study
of several neoplasms of the digestive tract, based on a network of
teaching and general hospitals from the Greater Milan area. Recruit
ment of cases of various cancers started between 1983 and 1985, and
the present report is based on data collected up to March 1988.
The general design of this investigation has already been described
(6). Briefly, trained interviewers identified and questioned patients
admitted to university and general hospitals in the area under surveil
lance for various cancers of the digestive tract and for a wide spectrum
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of other conditions. On the average, less than 2% of eligible subjects
(cases and controls) refused to be interviewed.
Cases. The cases studied were subjects below the age of 75 with
histologically confirmed cancer of the mouth or pharynx (n = 50),
esophagus (n = 209), stomach (n = 397), colon (n = 455), rectum (n =
295), liver (n = 151), and pancreas (n = 214) diagnosed within the year
before interview, who had been admitted to the National Cancer Insti
tute, to several university clinics (chiefly of surgery), and to the Ospedale
Maggiore, which includes the four largest teaching and general hospitals
in Milan.
Controls. Patients admitted for a wide spectrum of acute conditions
to several specialized university clinics and to the Ospedale Maggiore
of Milan were eligible as controls. None of these patients had malignant
tumors, digestive tract disorders, or any condition related to coffee,
alcohol, or tobacco consumption or which might have resulted in long-
term modification of diet. A total of 1944 controls (1334 males, 610
females) were interviewed. Of these, 38% were admitted for traumatic
conditions (mostly fractures and sprains), 15% had nontraumatic or
thopedic disorders (mostly lower back pain and disc disorders), 34%
were admitted for acute surgical conditions (including plastic surgery),
and 13% had other illness, such as ear, nose, and throat, skin, or dental
disorders. The median age of the comparison group was 56 years, and
the distribution of cases and controls according to age and sex is given
in Table 1. The catchment areas of cases and controls were well
comparable. Overall, 86% of the cases and 83% of the controls resided
in the same region, Lombardy; 6% of the cases and 4% of the controls
came from other Northern Italian regions; 8% of the cases and 13% of
the controls were from Central or Southern Italy.
A standard questionnaire was used to obtain information on socio
demographic factors and general characteristics and habits, including
smoking, alcohol, coffee, and other methylxanthine-containing bever
age consumption; a brief diet history based on 33 indicator foods;
related personal and family medical anamnesis; and history of use of
selected drugs.
Data Analysis and Control of Confounding. Relative risks of various
digestive tract neoplasms in relation to measures of coffee consumption,
together with their 95% approximate confidence intervals, were first
derived from data stratified for sex and age in decades (7). Secondly, to
account simultaneously for the potential confounding effect of several
factors, unconditional multiple logistic regression equations were fitted
(8), including terms for social class, education, marital status, smoking,
and alcohol consumption, besides age and sex.
RESULTS
Table 2 gives the distribution of cases of various digestive
tract neoplasms and the comparison group according to daily
consumption of caffeine-containing coffee. The corresponding
age- and sex-adjusted and multivariate relative risk estimates
according to approximate consumption tertiles (< 1; 2; >3 cups/
day) are reported in Table 3. No appreciable association was
evident with cancers of the mouth or pharynx, esophagus,
stomach, liver, and pancreas. For the latter neoplasm the point
estimates were 1.05 for 2 and 1.01 for 3 or more cups/day.
There were significant inverse trends for coffee consumption in
relation to cancers of the colon (multivariate relative risk, 0.64
for upper versus lower tertile) and rectum (relative risk, 0.66).
Both estimates were statistically significant.
The association between coffee drinking and cancers of the
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Table 1 Distribution of cases of selected digestive tract cancers and controls
according to sex and age: Milan, Italy, 1983-1988
Type of
cancerMouth
or
pharynx
Esophagus
Stomach
Colon
Rectum
Liver
PancreasMales
by age group(yr)<4510
21
22
12
12
1145-542446
51
3627
19
3755- 41271
85
77
65
54
4765-74635
86
86
66
30
41Females
by age group(yr)<451514
19
8
8
445-5438
31
45
18
6
1155-64319
52
75
45
12
2865-7415
57
95
54
10
3 Total50209
397
455
295
151
214
Controls 276 392 384 282 69 127 218 196 1944
Table 2 Distribution of selected digestive tract cancers and controls according to
sex and coffee consumption: Milan, Italy, 1983-1988
Males, cups/day Females, cups/day
Type ofcancerM uth
orpharynxEsophagusStomachColonRectumLiverPancreas091941513025181936485457273321445656350324335334727161517>4629422617162501733481981211542703411212193664387183210263318516>436171916511
Controls" 194 287 373 233 247 106 139 160 114 90
" The sum of strata does not add up to the total because of some missing
values.
Table 3 Relative risks of selected digestive tract cancers according to coffee
consumption: Milan, Italy, 1983-1988
Coffee consumption
(cups/day)Type
of cancer 0-1 2>3Mouth
orpharynxA"BEsophagusAnStomachABColonABRectumABLiverABPancreasAB'0.99*
0.86*
0.93*
0.90*
0.89*
0.94*
0.83*
0.86*
0.91*
0.97*
0.74*
0.79*
1.04*
1.050.790.811.130.981.011.260.590.640.620.660.640.781.031.01x,2
(trend)0.420.790.460.020.000.1714.89Â°10.37Â°8.23Â°4.80Â¿4.89''2.870.030.04
" A, estimates adjusted for sex and age only; B, estimates from multiple logistic
regression including terms for sex, age, social class, education, marital status,
smoking, coffee, and alcohol consumption.
* Reference category.
CP<0.0\.
d P< 0.05.
colon and rectum was further examined in Table 4 in separate
strata of age, sex, and other major covariates. No noticeable
interaction emerged with reference to colon cancer, the differ
ence between various point estimates being compatible with
random variation and an overall pattern of protection by greater
coffee drinking.
The picture was less consistent in relation to rectal cancer.
The protection was apparently restricted to males, the younger
age groups, or the heavy alcohol drinking categories, although
the interactions were not formally significant (except for sex).
These subgroup analyses, moreover, are rather insidious and
Table 4 Relative risks' of colon and rectal cancer according to coffee
consumption in separate slratax, of age, sex, and other covariates: Milan, Italy,
1983-1988
ColoncancerC ffee
con
sumption
(cups/day)CovariateSexMalesFemalesAge
(yr)<5050-5960-74Marital
statusNever
marriedEver
marriedEducation
(yr)<7S7Social
class1*MU
highestIV-VSmokingNever
smokersEx-smokersCurrent
smokersAlcohol
consumptionNondrinkers<4
drinks/dayâ€¢4
drinks/day20.810.880.130.810.961.130.870.920.820.811.000.980.890.630.910.970.68>30.610.630.750.610.740.610.650.650.600.680.550.660.710.480.420.820.55x,2
(trend)5.61*5.37*5.78*4.44*2.132.228.10e4.87*6.07*6.30*2.923.86*2.115.45*9.08'0.635.67*Rectal
cancerCoffee
con
sumption
(cups/day)20.821.230.791.090.960.900.990.861.250.781.031.011.020.880.981.210.81>30.500.920.370.820.280.500.690.670.710.520.660.691.080.220.571.020.37X,2
(trend)8.04f0.063. 20 281.701.693.313.191.093.98*2.751 890 098.11Â°2.380.098.50Â°
" Estimates from multiple logistic regression including the above variables.
Reference category: 0-1 cups/day.
*f<0.05.
'' Based on the head of the household's occupation.
the overall picture may well be reconciled within the general
smaller inverse association of coffee with rectal than with colon
cancer.
DISCUSSION
The findings of this network of case-control studies are
largely reassuring in relation to the effects of coffee consump
tion on the risk of digestive neoplasms. There was no associa
tion with neoplasms of mouth or pharynx, esophagus, stomach,
liver, and pancreas, and the risk of colorectal cancers was
reduced by greater levels of coffee consumption. For the latter
neoplasms, the protection was apparently stronger for colon
than for rectal cancer; in consideration of the difficulties in the
exact attribution of neoplasms arising at the colorectal junction
at one rather than the other site, it is indeed possible that the
reduced risk is largely or totally restricted to colon cancer. This
protection is consistent with some (9-12) but not all (13, 14)
previous epidemiological evidence of coffee and colonie cancers
and finds a plausible biological interpretation in terms of the
possible interference of coffee on bile secretion, reducing bile
acid and neutral sterol concentration in the bowel (IS).
Other possible explanations include the inhibition of chemi
cal carcinogenesis by caffeine (16-18) or other compounds in
coffee beans [i.e., kahweol palmitate, or cafesol palmitate (19)]
and an interaction with body weight (20). The first explanation,
however, is at present difficult to evaluate, since both inhibitory
and promotive (21, 22) effects of caffeine have been reported,
as well as to interpret in terms of site-specific carcinogenesis.
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In relation to the second explanation, in this study there was
no relation between measures of body weight and colorectal
cancer.
Considering the still largely unsettled epidemiological state
of knowledge, however, the present findings should chiefly be
viewed as offering further evidence on a debate of major rele
vance from the etiopathological and public health viewpoints.
With reference to another issue of substantial relevance in
the recent epidemiological debate, i.e., the possible positive
association between coffee and pancreatic cancer (23), the
present analyses [which update a previous paper dealing with
the issue in detail (24)] are reassuring, since the point estimates
for various levels of consumption were close to unity.
The present study is open to a series of criticisms. Although,
in fact, cases and controls came from well comparable catch
ment areas, they were interviewed in a similar setting, and
allowance was possible for major potential confounding factors
(such as social class, alcohol, or smoking) in multivariate anal
yses, the use of hospital controls for the analysis of life-style
risks, such as coffee, is still open to debate. It has been shown,
for instance, that patients admitted for chronic diseases tend to
report lower coffee consumption than those in hospital for
acute conditions (25). We excluded, therefore, all chronic and
digestive tract diseases from our comparison group and checked
the consistency of coffee drinking with the four major diagnostic
categories of controls (trauma, other acute orthopedics, acute
surgical, and other miscellaneous).
A major strength of this study, in our opinion, lies in the fact
that it provides an opportunity to obtain an overall pattern of
risk for various digestive tract neoplasms. In this regard, it is
reassuring that the relative risks were not elevated for any of
the neoplasms considered (and, indeed, various point estimates
tended to be below unity), which is clearly inconsistent with the
hypothesis of a substantial reduced coffee consumption in the
comparison group.
The effects of coffee in relation to various neoplastic diseases
were previously considered within the framework of three pro
spective studies, based on cohorts of Seventh-Day Adventists
(13, 26), Japanese men in Hawaii (14), and Norwegian men
(12). In the first study (13, 26), there was a significant positive
trend for colon, while in the second (14) some moderate (and
nonsignificant) protection was evident for rectal cancer. The
Norwegian prospective study (12) gave some hints of a lower
incidence of colon cancer with increased levels of coffee con
sumption, but no noticeable trend with any other digestive tract
neoplasms was observed. The absolute numbers of cases for
each single digestive tract neoplasm, however, were substan
tially lower in those cohort studies than in the present work.
In conclusion, therefore, the findings of this study, as well as
the overall previous evidence, are largely reassuring in relation
to the effect of coffee on digestive tract carcinogenesis. For no
site was there any consistent increase in risk, and there was
even a possibility of some protection by elevated coffee con
sumption on large intestine carcinogenesis.
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